A treatment option that allows doctors in the European Union (EU) to prescribe to patients, a promising medicine which has not yet been authorised (licensed) for their condition. It can only be used, if there are no other satisfactory authorised therapies, and the patient cannot enter a clinical trial. Each country has their own rules about how this can be used. In the UK this is known as the Early Access to Medicines Scheme (EAMS)
Have you been diagnosed with a brain tumour? Order your free information pack.
- Get support
- Signs & symptoms
- Diagnosis & treatment
- Living with a brain tumour
- Get involved
- Funding for researchers
- About us